Pyoderma Gangrenosum with Secondary Pyarthrosis Following Propylthiouracil
Overview
Authors
Affiliations
The association of pyoderma gangrenosum and arthritic symptoms is well documented. We present a rarely reported variant of this in a 44-year-old woman with pyoderma gangrenosum and bilateral large purulent effusions of her knees. She had no evidence of underlying rheumatoid arthritis or a specific seronegative spondyloarthropathy. Of note she had a history of Graves' disease for which she had been treated with propylthiouracil for 3 years and on investigation at this presentation had a markedly elevated perinuclear antineutrophil cytoplasm antibody (P-ANCA) level with specificities for IgM myeloperoxidase, IgG elastase and IgG lactoferrin. We believe this patient had pyoderma gangrenosum with secondary sterile pyarthrosis and a P-ANCA precipitated by propylthiouracil.
Khalaf R, Mhesin D, Abu Salim H, Taha S, Abed W Clin Diabetes Endocrinol. 2024; 10(1):42.
PMID: 39587631 PMC: 11587566. DOI: 10.1186/s40842-024-00215-3.
Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
Chen M, Gao Y, Guo X, Zhao M Nat Rev Nephrol. 2012; 8(8):476-83.
PMID: 22664738 DOI: 10.1038/nrneph.2012.108.
A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma Gangrenosum.
Seo J, Son H, Choi J, Lee S Ann Dermatol. 2010; 22(1):48-50.
PMID: 20548880 PMC: 2883396. DOI: 10.5021/ad.2010.22.1.48.
ANCA positive propylthiouracil induced pyoderma gangrenosum.
Gungor K, Gonen S, Kisakol G, Dikbas O, Kaya A J Endocrinol Invest. 2006; 29(6):575-6.
PMID: 16840840 DOI: 10.1007/BF03344152.